Blood & Blood Transfusion Policy

Blood & Blood Transfusion Policy – Nursing Study Notes

Blood & Blood Transfusion Policy

Comprehensive Nursing Study Notes

Nursing Education
Clinical Practice
Patient Safety
Blood Transfusion Process Illustration

Introduction to Blood Transfusion

Blood transfusion is a life-saving medical procedure involving the transfer of blood or blood components from a donor to a recipient. As a nursing professional, understanding the complexities of blood transfusion policy is crucial for ensuring patient safety and optimal outcomes. This comprehensive guide covers all aspects of blood transfusion from a nursing perspective, emphasizing evidence-based practice and patient-centered care.

Key Learning Objectives:

  • Understand blood physiology and compatibility principles
  • Master pre-transfusion assessment and verification procedures
  • Implement safe transfusion practices and monitoring protocols
  • Recognize and manage transfusion reactions
  • Apply legal and ethical considerations in transfusion medicine

Blood Anatomy & Physiology

Blood Components

Red Blood Cells (45%)

Oxygen transport, CO2 removal, contain hemoglobin

Plasma (55%)

Fluid component, proteins, electrolytes, nutrients

Platelets (<1%)

Clotting function, hemostasis

White Blood Cells (<1%)

Immune function, infection fighting

Normal Values

Hemoglobin 12-16 g/dL (F), 14-18 g/dL (M)
Hematocrit 36-46% (F), 41-53% (M)
Platelets 150,000-450,000/μL
Total Blood Volume 7% of body weight

Mnemonic: Blood Functions

“TORCH”

  • Transport (oxygen, nutrients, waste)
  • Oncotic pressure maintenance
  • Regulation (pH, temperature)
  • Clotting and hemostasis
  • Homeostasis and immunity

Blood Types & Compatibility

ABO System

Type A

A antigens, anti-B antibodies

Can receive: A, O | Can donate to: A, AB

Type B

B antigens, anti-A antibodies

Can receive: B, O | Can donate to: B, AB

Type AB

A & B antigens, no antibodies

Universal recipient

Type O

No antigens, anti-A & anti-B antibodies

Universal donor

Rh System

Rh Positive (+)

Rh D antigen present

85% of population

Rh Negative (-)

Rh D antigen absent

15% of population

Critical Compatibility Rule

Rh-negative patients should receive Rh-negative blood to prevent sensitization, especially in women of childbearing age.

Mnemonic: Blood Compatibility

“A-B-O, Always Be Observant”

Type A: “A” can Accept from A and O

Type B: “B” can Borrow from B and O

Type AB: “AB” Accepts Both (universal recipient)

Type O: “O” Offers to all (universal donor)

Blood Products

Packed Red Blood Cells (PRBCs)

Volume: 250-300 mL

Storage: 1-6°C, 35-42 days

Indications: Anemia, blood loss

Infusion Rate: 1-2 mL/kg/hr

Expected Rise: Hgb 1g/dL, Hct 3%

Fresh Frozen Plasma (FFP)

Volume: 200-250 mL

Storage: -18°C, 12 months

Indications: Coagulopathy, factor deficiency

Infusion Rate: As fast as tolerated

Thaw Time: 30-45 minutes

Platelets

Volume: 50-70 mL/unit

Storage: 20-24°C, 5 days

Indications: Thrombocytopenia, bleeding

Infusion Rate: As fast as tolerated

Expected Rise: 30,000-60,000/μL

Cryoprecipitate

Volume: 10-15 mL/unit

Storage: -18°C, 12 months

Indications: Fibrinogen deficiency, DIC

Contains: Factor VIII, fibrinogen, vWF

Dosing: 1 unit/10 kg body weight

Albumin

Concentrations: 5%, 25%

Storage: Room temperature

Indications: Hypovolemia, hypoalbuminemia

Half-life: 15-20 days

Onset: Immediate volume expansion

Immunoglobulins

Types: IVIG, anti-D, specific antibodies

Storage: 2-8°C

Indications: Immunodeficiency, autoimmune

Infusion: Slow initial rate

Duration: 3-4 weeks effect

Transfusion Indications

PRBC Transfusion Decision Tree

Patient Assessment

Hemoglobin, symptoms, comorbidities

Hgb < 7 g/dL

Generally transfuse

Hgb 7-10 g/dL

Consider symptoms & risk factors

Hgb > 10 g/dL

Rarely indicated

Absolute Indications

  • Acute blood loss >30% blood volume
  • Hemoglobin <7 g/dL with symptoms
  • Active bleeding with hemodynamic instability
  • Severe anemia with cardiac symptoms

Relative Indications

  • Hemoglobin 7-10 g/dL with risk factors
  • Pre-operative optimization
  • Chronic anemia with functional impairment
  • Failed response to iron therapy

Special Populations

Pediatric

15 mL/kg for PRBC

10-15 mL/kg for FFP

Elderly

Consider cardiac status

Slower infusion rates

Cardiac Patients

Higher threshold (Hgb 8-10)

Monitor fluid status

Pre-transfusion Procedures

Physician Orders

  • Type of blood product
  • Number of units
  • Rate of administration
  • Special requirements (irradiated, CMV-negative)
  • Pre-medication orders

Informed Consent

  • Explain risks and benefits
  • Discuss alternatives
  • Address patient concerns
  • Document consent process
  • Respect religious/cultural beliefs

Pre-transfusion Checklist

1

Patient ID

Two identifiers minimum

2

Blood Sample

Type & crossmatch

3

Baseline Vitals

T, P, R, BP

4

IV Access

18-gauge or larger

Critical Safety Checks

Patient History

  • • Previous transfusions
  • • Transfusion reactions
  • • Pregnancy history
  • • Recent medications

Laboratory Requirements

  • • ABO/Rh typing
  • • Antibody screen
  • • Crossmatch compatibility
  • • Sample age <72 hours

Transfusion Process

Transfusion Workflow

Retrieve
Blood from bank
Verify
Two-person check
Prime
Blood tubing
Start
Slow initial rate
Monitor
Patient response
Complete
Document

Two-Person Verification

Patient Identification

  • • Full name
  • • Date of birth
  • • Medical record number
  • • Patient wristband

Blood Product Verification

  • • Unit number
  • • ABO/Rh type
  • • Expiration date
  • • Crossmatch compatibility

Infusion Guidelines

Initial Rate 1-2 mL/min for 15 minutes
Standard Rate 2-4 hours per unit
Maximum Time 4 hours per unit
Emergency Rate Wide open with pressure
Filter 170-260 micron standard

Mnemonic: Verification Process

“RIGHT PERSON, RIGHT PRODUCT”

Recipient identification

Inspect blood product

General condition check

History review

Two-person verification

Product compatibility

Expiration date

Reaction history

Signatures required

Observe throughout

No interruptions during verification

Monitoring & Safety

First 15 Minutes

  • • Stay with patient
  • • Vital signs every 5 minutes
  • • Watch for immediate reactions
  • • Slow infusion rate (1-2 mL/min)
  • • Document observations

During Transfusion

  • • Vital signs every 30 minutes
  • • Assess patient comfort
  • • Monitor IV site
  • • Check urine output
  • • Observe skin color

Post-Transfusion

  • • Final vital signs
  • • Assess overall response
  • • Monitor for delayed reactions
  • • Complete documentation
  • • Follow-up lab values

Vital Signs Monitoring Schedule

Baseline
Before start
5 min
Early monitoring
15 min
End of caution period
30 min
Routine intervals
End
Final assessment

Red Flag Signs – STOP TRANSFUSION

Immediate Signs

  • • Fever (>1°C rise)
  • • Chills or rigors
  • • Hypotension
  • • Tachycardia
  • • Difficulty breathing

Other Concerning Signs

  • • Nausea/vomiting
  • • Back or chest pain
  • • Skin rash or flushing
  • • Dark urine
  • • Anxiety or sense of doom

Adverse Reactions

Acute Hemolytic

Cause: ABO incompatibility

Onset: Immediate

Signs: Fever, chills, back pain, hemoglobinuria

Action: STOP immediately, support BP, diuresis

Mortality: High if severe

Febrile Non-Hemolytic

Cause: Antibodies to WBC/platelets

Onset: During or within 4 hours

Signs: Fever >1°C, chills, malaise

Action: Stop, antipyretics, rule out hemolysis

Prevention: Leukoreduced products

Allergic

Cause: Proteins in donor plasma

Onset: Usually immediate

Signs: Urticaria, itching, mild dyspnea

Action: Stop, antihistamines, epinephrine if severe

Prevention: Washed RBCs

TACO

Cause: Volume overload

Onset: During or within 6 hours

Signs: Dyspnea, hypertension, JVD

Action: Stop, diuretics, O2 support

Prevention: Slow rate, monitor closely

TRALI

Cause: Donor antibodies to recipient neutrophils

Onset: Within 6 hours

Signs: Acute respiratory distress, fever

Action: Stop, ventilatory support

Key: Normal CVP (vs TACO)

Infectious

Cause: Contains pathogens

Onset: Days to months

Risk: Very low with modern screening

Examples: HIV, Hepatitis, CMV, bacteria

Prevention: Donor screening, testing

Transfusion Reaction Management

Suspect Reaction

Any abnormal sign/symptom

STOP TRANSFUSION

Keep IV line open with normal saline

Assess Patient

Vital signs, symptoms

Notify Physician

Report immediately

Blood Bank

Return unit, send samples

Mnemonic: Reaction Assessment

“STOP, THINK, ACT”

STOP

• Stop transfusion

• Stay with patient

• Support airway/breathing

THINK

• Type of reaction

• Hemolytic vs non-hemolytic

• Immediate vs delayed

ACT

• Alert physician

• Administer treatment

• Arrange for follow-up

Post-transfusion Care

Immediate Assessment (0-4 hours)

  • Monitor vital signs every 30 minutes × 2 hours
  • Assess for delayed reactions
  • Check IV site for complications
  • Monitor urine output and color
  • Document patient tolerance

Laboratory Follow-up

  • CBC 1-4 hours post-transfusion
  • Assess hemoglobin response
  • Platelet count if platelets given
  • Coagulation studies if FFP given
  • LDH, bilirubin if hemolysis suspected

Expected Responses

PRBC Transfusion

  • • Hgb ↑ 1 g/dL per unit
  • • Hct ↑ 3% per unit
  • • Improved energy, less fatigue
  • • Better exercise tolerance

Platelet Transfusion

  • • Count ↑ 30,000-60,000/μL
  • • Reduced bleeding tendency
  • • Petechiae resolution
  • • Improved clotting

FFP Transfusion

  • • PT/INR improvement
  • • aPTT normalization
  • • Reduced bleeding
  • • Volume expansion

Documentation Requirements

Patient Info

  • • ID verification
  • • Consent obtained
  • • Baseline vitals

Product Details

  • • Unit numbers
  • • Blood type
  • • Expiration dates

Timeline

  • • Start/stop times
  • • Vital sign times
  • • Rate changes

Response

  • • Patient tolerance
  • • Any reactions
  • • Final assessment

Nursing Implementation

Nursing Process Application

Assessment

  • • Health history
  • • Current status
  • • Lab values
  • • Risk factors

Diagnosis

  • • Risk for injury
  • • Anxiety
  • • Fluid volume excess
  • • Knowledge deficit

Planning

  • • Safety goals
  • • Patient outcomes
  • • Intervention strategies
  • • Resource allocation

Implementation

  • • Safe practices
  • • Patient monitoring
  • • Education provision
  • • Reaction management

Evaluation

  • • Goal achievement
  • • Patient response
  • • Complications
  • • Plan revision

Core Nursing Competencies

Clinical Skills

  • • Patient identification techniques
  • • IV access and maintenance
  • • Vital sign monitoring
  • • Reaction recognition and response

Communication

  • • Patient education
  • • Interdisciplinary collaboration
  • • Family involvement
  • • Documentation accuracy

Critical Thinking

  • • Risk assessment
  • • Priority setting
  • • Problem solving
  • • Evidence-based practice

Patient Education Topics

Pre-transfusion

  • • Procedure explanation
  • • Expected duration
  • • Monitoring requirements
  • • Signs to report

During transfusion

  • • Comfort measures
  • • Activity restrictions
  • • Symptom reporting
  • • Emotional support

Post-transfusion

  • • Expected outcomes
  • • Delayed reaction signs
  • • Follow-up requirements
  • • Lifestyle considerations

Nursing Interventions by Phase

Phase Priority Interventions Monitoring Focus Documentation
Pre-transfusion Consent, ID verification, IV access, baseline vitals Anxiety level, understanding, physical status Consent, baseline assessment, patient teaching
Initial 15 min Slow rate, stay with patient, frequent vitals Signs of acute reactions, vital sign changes Vital signs, patient tolerance, rate adjustments
During transfusion Regular monitoring, comfort measures, IV maintenance Ongoing tolerance, IV patency, symptoms Vital signs, patient response, any interventions
Post-transfusion Final assessment, line care, follow-up planning Overall response, delayed reactions, lab results Final assessment, patient outcomes, discharge planning

Quality Assurance & Best Practices

Safety Culture

  • • Error reporting without blame
  • • Continuous learning environment
  • • Team communication
  • • Standardized procedures
  • • Regular competency validation

Performance Metrics

  • • Transfusion reaction rates
  • • Identification error incidents
  • • Compliance with protocols
  • • Patient satisfaction scores
  • • Staff competency rates

Education & Training

  • • Initial competency training
  • • Annual recertification
  • • Simulation exercises
  • • Case study reviews
  • • Policy updates training

Best Practice Standards

The Joint Commission Requirements

  • • Patient Safety Goals compliance
  • • Two-patient identifier use
  • • Timeout procedures
  • • Medication reconciliation
  • • Hand-off communication

AABB Standards

  • • Blood bank accreditation
  • • Quality management systems
  • • Proficiency testing
  • • Equipment validation
  • • Personnel qualifications

Continuous Improvement Cycle

Assess

Current practices

Plan

Improvements

Implement

Changes

Evaluate

Outcomes

Final Mnemonic: Excellence in Transfusion

“SAFE TRANSFUSION”

Safety first priority

Accurate identification

Frequent monitoring

Education of patient/family

Two-person verification

Reaction recognition

Assessment continuous

Never rush the process

Standard precautions

Follow protocols strictly

Understand patient needs

Support emotional needs

Involve interdisciplinary team

Optimal outcomes focus

Nurse advocacy essential

Key Takeaways

Critical Success Factors:

  • • Patient safety is paramount
  • • Accurate identification prevents errors
  • • Early recognition saves lives
  • • Communication prevents complications
  • • Documentation protects everyone

Nursing Excellence Requires:

  • • Continuous learning and competency
  • • Evidence-based practice application
  • • Patient-centered care approach
  • • Ethical decision-making skills
  • • Collaborative team relationships

Blood & Blood Transfusion Policy – Nursing Study Notes

Comprehensive Educational Resource for Professional Practice

Evidence-Based
Educational Focus
Patient-Centered

Leave a Reply

Your email address will not be published. Required fields are marked *